209 related articles for article (PubMed ID: 27385179)
1. Comparing Various In Vitro Prediction Criteria to Assess the Potential of a New Molecular Entity to Inhibit Organic Anion Transporting Polypeptide 1B1.
Vaidyanathan J; Yoshida K; Arya V; Zhang L
J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S59-72. PubMed ID: 27385179
[TBL] [Abstract][Full Text] [Related]
2. Investigation of the impact of substrate selection on in vitro organic anion transporting polypeptide 1B1 inhibition profiles for the prediction of drug-drug interactions.
Izumi S; Nozaki Y; Maeda K; Komori T; Takenaka O; Kusuhara H; Sugiyama Y
Drug Metab Dispos; 2015 Feb; 43(2):235-47. PubMed ID: 25414411
[TBL] [Abstract][Full Text] [Related]
3. Solitary Inhibition of the Breast Cancer Resistance Protein Efflux Transporter Results in a Clinically Significant Drug-Drug Interaction with Rosuvastatin by Causing up to a 2-Fold Increase in Statin Exposure.
Elsby R; Martin P; Surry D; Sharma P; Fenner K
Drug Metab Dispos; 2016 Mar; 44(3):398-408. PubMed ID: 26700956
[TBL] [Abstract][Full Text] [Related]
4. Investigation of Fluorescein Derivatives as Substrates of Organic Anion Transporting Polypeptide (OATP) 1B1 To Develop Sensitive Fluorescence-Based OATP1B1 Inhibition Assays.
Izumi S; Nozaki Y; Komori T; Takenaka O; Maeda K; Kusuhara H; Sugiyama Y
Mol Pharm; 2016 Feb; 13(2):438-48. PubMed ID: 26696140
[TBL] [Abstract][Full Text] [Related]
5. Substrate-dependent inhibition of organic anion transporting polypeptide 1B1: comparative analysis with prototypical probe substrates estradiol-17β-glucuronide, estrone-3-sulfate, and sulfobromophthalein.
Izumi S; Nozaki Y; Komori T; Maeda K; Takenaka O; Kusano K; Yoshimura T; Kusuhara H; Sugiyama Y
Drug Metab Dispos; 2013 Oct; 41(10):1859-66. PubMed ID: 23920221
[TBL] [Abstract][Full Text] [Related]
6. Pre-incubation with cyclosporine A potentiates its inhibitory effects on pitavastatin uptake mediated by recombinantly expressed cynomolgus monkey hepatic organic anion transporting polypeptide.
Takahashi T; Ohtsuka T; Uno Y; Utoh M; Yamazaki H; Kume T
Biopharm Drug Dispos; 2016 Nov; 37(8):479-490. PubMed ID: 27603548
[TBL] [Abstract][Full Text] [Related]
7. Proposal of a Parameter for OATP1B1 Inhibition Screening at the Early Drug Discovery Stage.
Murata H; Ito S; Kusuhara H; Nomura Y; Taniguchi T
J Pharm Sci; 2019 Dec; 108(12):3898-3902. PubMed ID: 31446145
[TBL] [Abstract][Full Text] [Related]
8. Generation of Bayesian prediction models for OATP-mediated drug-drug interactions based on inhibition screen of OATP1B1, OATP1B1∗15 and OATP1B3.
van de Steeg E; Venhorst J; Jansen HT; Nooijen IH; DeGroot J; Wortelboer HM; Vlaming ML
Eur J Pharm Sci; 2015 Apr; 70():29-36. PubMed ID: 25603031
[TBL] [Abstract][Full Text] [Related]
9. Influence of non-steroidal anti-inflammatory drugs on organic anion transporting polypeptide (OATP) 1B1- and OATP1B3-mediated drug transport.
Kindla J; Müller F; Mieth M; Fromm MF; König J
Drug Metab Dispos; 2011 Jun; 39(6):1047-53. PubMed ID: 21389119
[TBL] [Abstract][Full Text] [Related]
10. Prediction of organic anion-transporting polypeptide 1B1- and 1B3-mediated hepatic uptake of statins based on transporter protein expression and activity data.
Kunze A; Huwyler J; Camenisch G; Poller B
Drug Metab Dispos; 2014 Sep; 42(9):1514-21. PubMed ID: 24989890
[TBL] [Abstract][Full Text] [Related]
11. Static Model-Based Assessment of OATP1B1-Mediated Drug Interactions with Preincubation-Dependent Inhibitors Based on Inactivation and Recovery Kinetics.
Taguchi T; Masuo Y; Futatsugi A; Kato Y
Drug Metab Dispos; 2020 Sep; 48(9):750-758. PubMed ID: 32616544
[TBL] [Abstract][Full Text] [Related]
12. Organic anion transporting polypeptide (OATP)1B1 and OATP1B3 as important regulators of the pharmacokinetics of substrate drugs.
Maeda K
Biol Pharm Bull; 2015; 38(2):155-68. PubMed ID: 25747975
[TBL] [Abstract][Full Text] [Related]
13. Characterization of 22 Antituberculosis Drugs for Inhibitory Interaction Potential on Organic Anionic Transporter Polypeptide (OATP)-Mediated Uptake.
Parvez MM; Jung JA; Shin HJ; Kim DH; Shin JG
Antimicrob Agents Chemother; 2016 May; 60(5):3096-105. PubMed ID: 26976869
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of organic anion transporting polypeptide 1B1 and 1B3 humanized mice as a translational model to study the pharmacokinetics of statins.
Salphati L; Chu X; Chen L; Prasad B; Dallas S; Evers R; Mamaril-Fishman D; Geier EG; Kehler J; Kunta J; Mezler M; Laplanche L; Pang J; Rode A; Soars MG; Unadkat JD; van Waterschoot RA; Yabut J; Schinkel AH; Scheer N
Drug Metab Dispos; 2014 Aug; 42(8):1301-13. PubMed ID: 24855184
[TBL] [Abstract][Full Text] [Related]
15. Prediction and Quantification of Hepatic Transporter-Mediated Uptake of Pitavastatin Utilizing a Combination of the Relative Activity Factor Approach and Mechanistic Modeling.
Mitra P; Weinheimer S; Michalewicz M; Taub ME
Drug Metab Dispos; 2018 Jul; 46(7):953-963. PubMed ID: 29666154
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous Assessment of Transporter-Mediated Drug-Drug Interactions Using a Probe Drug Cocktail in Cynomolgus Monkey.
Kosa RE; Lazzaro S; Bi YA; Tierney B; Gates D; Modi S; Costales C; Rodrigues AD; Tremaine LM; Varma MV
Drug Metab Dispos; 2018 Aug; 46(8):1179-1189. PubMed ID: 29880631
[TBL] [Abstract][Full Text] [Related]
17. Preclinical Mouse Models To Study Human OATP1B1- and OATP1B3-Mediated Drug-Drug Interactions in Vivo.
Durmus S; Lozano-Mena G; van Esch A; Wagenaar E; van Tellingen O; Schinkel AH
Mol Pharm; 2015 Dec; 12(12):4259-69. PubMed ID: 26474710
[TBL] [Abstract][Full Text] [Related]
18. Drug-drug interaction between pitavastatin and various drugs via OATP1B1.
Hirano M; Maeda K; Shitara Y; Sugiyama Y
Drug Metab Dispos; 2006 Jul; 34(7):1229-36. PubMed ID: 16595711
[TBL] [Abstract][Full Text] [Related]
19. The influence of macrolide antibiotics on the uptake of organic anions and drugs mediated by OATP1B1 and OATP1B3.
Seithel A; Eberl S; Singer K; Auge D; Heinkele G; Wolf NB; Dörje F; Fromm MF; König J
Drug Metab Dispos; 2007 May; 35(5):779-86. PubMed ID: 17296622
[TBL] [Abstract][Full Text] [Related]
20. Contribution of organic anion transporting polypeptide (OATP) 1B1 and OATP1B3 to hepatic uptake of nateglinide, and the prediction of drug-drug interactions via these transporters.
Takanohashi T; Kubo S; Arisaka H; Shinkai K; Ubukata K
J Pharm Pharmacol; 2012 Feb; 64(2):199-206. PubMed ID: 22221095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
